• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受中心血液透析的终末期肾病患者的隐匿性未控制高血压

Masked uncontrolled hypertension in patients with end-stage kidney disease on in-center hemodialysis.

作者信息

Nguyen Hoang Hai, Trinh Ngan Thi Thanh, Tran Minh-Hoang, Pham Hong Tham

机构信息

Department of Cardiac Intensive Care and Cardiomyopathy, Nhan Dan Gia Dinh Hospital, Ho Chi Minh City, Vietnam.

Department of Cardiology, Trung Vuong Hospital, Ho Chi Minh City, Vietnam.

出版信息

BMC Cardiovasc Disord. 2025 Apr 2;25(1):245. doi: 10.1186/s12872-025-04679-8.

DOI:10.1186/s12872-025-04679-8
PMID:40175932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11963420/
Abstract

BACKGROUND

Masked uncontrolled hypertension (MUCH) is associated with an increasing risk of morbidity and mortality. Current literature on MUCH lacks data on patients with end-stage kidney disease (ESKD) on hemodialysis (HD). We aimed to investigate the prevalence, ambulatory blood pressure (BP) characteristics, and risk factors of MUCH in this population in a low-middle-income Asian country.

METHODS

We conducted a simple random-sampling, cross-sectional study on patients with hypertension and ESKD on HD. The outcome was MUCH, which was confirmed if the participants, who were on 24-hour ambulatory BP monitoring, had at least 1 of the following criteria: (1) daytime mean ambulatory BP ≥ 135 mmHg (systolic) and/or ≥ 85 mmHg (diastolic); (2) night-time mean ambulatory BP ≥ 120 mmHg (systolic) and/or ≥ 70 mmHg (diastolic); or (3) 24-hour mean ambulatory BP ≥ 130 mmHg (systolic) and/or ≥ 80 mmHg (diastolic). Data were presented using descriptive statistics. We used logistic regression to explore the risk factors for MUCH, and the results were reported with odds ratio (OR) and 95% confidence interval (95% CI).

RESULTS

Among 104 participants included for analysis (median age 54.5, 48.1% being female), MUCH was reported on 85 of them (prevalence of 81.7%, 95% CI 73.2-88.0%.). Non-dipping status of BP were found in 98.1% of the participants, with non-dippers dominating the normotension group (prevalence of 57.9%, 95% CI 36.3-76.9%) and reverse dippers dominating the MUCH group (prevalence of 65.9%, 95% CI 55.3-75.1%). We also identified some factors that were associated with a higher risk of MUCH, i.e., being current smoker (adjusted OR = 3.49, 95% CI 1.07 to 11.40), undergoing HD for > 48 months (adjusted OR = 5.69, 95% CI 1.48 to 21.81), taking > 3 antihypertensive medications (adjusted OR = 3.64, 95% CI 1.11 to 11.92), and requiring α2-adrenergic receptor agonists for BP control (adjusted OR = 6.31, 95% CI 1.12 to 35.62).

CONCLUSION

The prevalences of MUCH and non-dipping of BP (non-dipper and reverse dipper) were very high in patients with ESKD who were undergoing HD for a median duration of 6 years without ambulatory BP monitoring. To avoid extra cost and inconvenience, risk factors should be initially screened for MUCH before monitoring out-of-office BP for a confirmed diagnosis.

摘要

背景

隐匿性未控制高血压(MUCH)与发病和死亡风险增加相关。目前关于MUCH的文献缺乏终末期肾病(ESKD)血液透析(HD)患者的数据。我们旨在调查一个中低收入亚洲国家该人群中MUCH的患病率、动态血压(BP)特征及危险因素。

方法

我们对HD的高血压和ESKD患者进行了简单随机抽样横断面研究。结局为MUCH,如果进行24小时动态血压监测的参与者符合以下至少一项标准则确诊:(1)日间平均动态血压≥135 mmHg(收缩压)和/或≥85 mmHg(舒张压);(2)夜间平均动态血压≥120 mmHg(收缩压)和/或≥70 mmHg(舒张压);或(3)24小时平均动态血压≥130 mmHg(收缩压)和/或≥80 mmHg(舒张压)。数据采用描述性统计呈现。我们使用逻辑回归探索MUCH的危险因素,结果以比值比(OR)和95%置信区间(95%CI)报告。

结果

纳入分析的104名参与者(中位年龄54.5岁,48.1%为女性)中,85人报告患有MUCH(患病率81.7%,95%CI 73.2 - 88.0%)。98.1%的参与者存在血压非勺型状态,非勺型在血压正常组占主导(患病率57.9%,95%CI 36.3 - 76.9%),反勺型在MUCH组占主导(患病率65.9%,95%CI 55.3 - 75.1%)。我们还确定了一些与MUCH风险较高相关的因素,即当前吸烟者(调整后OR = 3.49,95%CI 1.07至11.40)、HD治疗时间>48个月(调整后OR = 5.69,95%CI 1.48至21.81)、服用>3种抗高血压药物(调整后OR = 3.64,95%CI 1.11至11.92)以及需要α2肾上腺素能受体激动剂控制血压(调整后OR = 6.31,95%CI 1.12至35.62)。

结论

在未进行动态血压监测且HD治疗中位时长为6年的ESKD患者中,MUCH和血压非勺型状态(非勺型和反勺型)的患病率非常高。为避免额外费用和不便,在进行诊室外血压监测以确诊之前,应首先筛查MUCH的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef7f/11963420/f214953191aa/12872_2025_4679_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef7f/11963420/e1ce098ad092/12872_2025_4679_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef7f/11963420/f214953191aa/12872_2025_4679_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef7f/11963420/e1ce098ad092/12872_2025_4679_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef7f/11963420/f214953191aa/12872_2025_4679_Fig2_HTML.jpg

相似文献

1
Masked uncontrolled hypertension in patients with end-stage kidney disease on in-center hemodialysis.接受中心血液透析的终末期肾病患者的隐匿性未控制高血压
BMC Cardiovasc Disord. 2025 Apr 2;25(1):245. doi: 10.1186/s12872-025-04679-8.
2
Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH).高血压患者的血压控制、心血管风险状况及隐匿性未控制高血压(MUCH)的患病率
Med Arch. 2016 Jul 27;70(4):274-279. doi: 10.5455/medarh.2016.70.274-279.
3
Prevalence and Characteristics of Isolated Nighttime Masked Uncontrolled Hypertension in Treated Patients.治疗患者中孤立的夜间掩蔽性未控制高血压的患病率和特征。
Medicina (Kaunas). 2024 Sep 18;60(9):1522. doi: 10.3390/medicina60091522.
4
Toward a definition of masked hypertension and white-coat hypertension among hemodialysis patients.针对血液透析患者中掩蔽性高血压和白大衣性高血压的定义。
Clin J Am Soc Nephrol. 2011 Aug;6(8):2003-8. doi: 10.2215/CJN.02700311. Epub 2011 Jul 7.
5
Masked uncontrolled hypertension among elderly black sub-saharan africans compared to younger adults: a cross-sectional in-hospital study.撒哈拉以南非洲老年黑人与年轻成年人相比的隐匿性未控制高血压:一项横断面住院研究。
BMC Cardiovasc Disord. 2024 Sep 4;24(1):472. doi: 10.1186/s12872-024-04150-0.
6
Masked Uncontrolled Hypertension in CKD.慢性肾脏病中的隐匿性未控制高血压
J Am Soc Nephrol. 2016 Mar;27(3):924-32. doi: 10.1681/ASN.2015030243. Epub 2015 Jul 10.
7
Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients.动态血压监测检出的老年高血压患者隐匿性和白大衣性未控制高血压的预后。
Am J Hypertens. 2017 Nov 1;30(11):1106-1111. doi: 10.1093/ajh/hpx104.
8
Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study.CKD 患者动态血压监测的预后意义:来自慢性肾功能不全队列(CRIC)研究的报告。
J Am Soc Nephrol. 2020 Nov;31(11):2609-2621. doi: 10.1681/ASN.2020030236. Epub 2020 Sep 24.
9
Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary Study.强化与标准诊室高血压治疗策略对白衣效应和隐匿性未控制高血压的影响:来自 SPRINT 动态血压监测辅助研究。
Hypertension. 2020 Oct;76(4):1090-1096. doi: 10.1161/HYPERTENSIONAHA.120.15300. Epub 2020 Aug 24.
10
Prevalence of masked hypertension in attended versus unattended office blood pressure measurement.在有医护人员参与和无医护人员参与的诊室血压测量中,隐匿性高血压的患病率。
J Clin Hypertens (Greenwich). 2024 Jun;26(6):615-623. doi: 10.1111/jch.14798. Epub 2024 May 15.

本文引用的文献

1
Hypertension in Patients Treated With In-Center Maintenance Hemodialysis: Current Evidence and Future Opportunities: A Scientific Statement From the American Heart Association.中心维持性血液透析患者的高血压:当前证据与未来机遇:美国心脏协会科学声明。
Hypertension. 2023 Jun;80(6):e112-e122. doi: 10.1161/HYP.0000000000000230. Epub 2023 Apr 24.
2
Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association.人类血压测量:美国心脏协会的科学声明。
Hypertension. 2019 May;73(5):e35-e66. doi: 10.1161/HYP.0000000000000087.
3
Hypertension in patients on dialysis: diagnosis, mechanisms, and management.
透析患者的高血压:诊断、机制与管理
J Bras Nefrol. 2019 Jul-Sep;41(3):400-411. doi: 10.1590/2175-8239-jbn-2018-0155. Epub 2018 Nov 8.
4
Masked Uncontrolled Hypertension.隐匿性未控制高血压
Hypertension. 2018 Oct;72(4):843-845. doi: 10.1161/HYPERTENSIONAHA.118.11640.
5
Prognostic Value of Masked Uncontrolled Hypertension.隐匿性未控制高血压的预后价值。
Hypertension. 2018 Oct;72(4):862-869. doi: 10.1161/HYPERTENSIONAHA.118.11499.
6
2018 ESC/ESH Guidelines for the management of arterial hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南。
Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339.
7
Masked uncontrolled hypertension in patients on maintenance hemodialysis.维持性血液透析患者的掩蔽性未控制高血压。
Hypertens Res. 2017 Sep;40(9):819-824. doi: 10.1038/hr.2017.48. Epub 2017 Apr 6.
8
Masked Uncontrolled Hypertension in CKD.慢性肾脏病中的隐匿性未控制高血压
J Am Soc Nephrol. 2016 Mar;27(3):924-32. doi: 10.1681/ASN.2015030243. Epub 2015 Jul 10.
9
Significance of white-coat and masked hypertension in chronic kidney disease and end-stage renal disease.白大衣高血压和隐匿性高血压在慢性肾脏病和终末期肾病中的意义。
Hypertens Res. 2014 Oct;37(10):882-9. doi: 10.1038/hr.2014.82. Epub 2014 Apr 17.
10
High prevalence of masked uncontrolled hypertension in people with treated hypertension.高血压患者中普遍存在未被发现的未控制高血压。
Eur Heart J. 2014 Dec 7;35(46):3304-12. doi: 10.1093/eurheartj/ehu016. Epub 2014 Feb 3.